Your browser doesn't support javascript.
loading
Functional analysis of circSNYJ1/miR-142-5p/CCND1 regulatory axis in non-small cell lung cancer.
Yan, Jie; Chen, Enping; Li, Yu; Fang, Yukun; Deng, Yong.
Afiliación
  • Yan J; Department of Respiratory Medicine, 903rd Hospital of PLA No. 14 Lingyin Road, Hangzhou 310000, Zhejiang, China.
  • Chen E; Department of Disease Prevention and Control, 903rd Hospital of PLA No. 14 Lingyin Road, Hangzhou 310000, Zhejiang, China.
  • Li Y; Department of Respiratory Medicine, 903rd Hospital of PLA No. 14 Lingyin Road, Hangzhou 310000, Zhejiang, China.
  • Fang Y; Department of Respiratory Medicine, 903rd Hospital of PLA No. 14 Lingyin Road, Hangzhou 310000, Zhejiang, China.
  • Deng Y; Department of Neurosurgery, 903rd Hospital of PLA No. 14 Lingyin Road, Hangzhou 310000, Zhejiang, China.
Am J Cancer Res ; 14(7): 3483-3496, 2024.
Article en En | MEDLINE | ID: mdl-39113852
ABSTRACT
Non-small cell lung cancer (NSCLC), the most prevalent form of lung cancer, accounts for approximately 85% of all lung cancer diagnoses. Circular RNAs (circRNAs) are non-coding RNAs that play an active role in gene expression regulation, influencing cell growth, migration, and apoptosis. Here, we aimed to investigate the function of circSNYJ1 in NSCLC. In the present study, we found that circSNYJ1 expression level was increased in NSCLC tissues and cell lines. Knockdown of circSNYJ1 suppressed NSCLC cell proliferation, colony formation and migration while promoting apoptosis. Mechanistically, we demonstrated that circSNYJ1 sponged miR-142-5p, thereby regulating the expression of CCND1, a well-known cell cycle regulator. In conclusion, this study uncovered a novel circSNYJ1/miR-142-5p/CCND1 axis involved in NSCLC progression, providing potential diagnostic and prognostic biomarkers for treating NSCLC.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2024 Tipo del documento: Article País de afiliación: China